Company Filing History:
1 out of 517 
1 out of 108 
Years Active: 2018
Title: James Petrik: Innovator in Thrombospondin-1 Polypeptides
Introduction
James Petrik is a notable inventor based in Rockwood, CA. He has made significant contributions to the field of biomedical research, particularly in the development of thrombospondin-1 polypeptides. His work focuses on innovative methods that have the potential to impact treatments for various disorders, including cancer.
Latest Patents
James Petrik holds a patent for "Thrombospondin-1 polypeptides and methods of using same." This invention features thrombospondin-1 (TSP-1) polypeptides, such as 3TSR-Fc fusion proteins, along with nucleic acid molecules encoding these polypeptides. The patent also outlines methods for making and utilizing TSP-1 polypeptides, particularly in treating disorders associated with pathological angiogenesis, including epithelial ovarian cancer (EOC).
Career Highlights
Throughout his career, James has worked with esteemed institutions such as Beth Israel Deaconess Medical Center, Inc. and the University of Guelph. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
James has collaborated with notable colleagues, including John W. Lawler and Mark Duquette. These partnerships have further enriched his research and innovation efforts.
Conclusion
James Petrik's work in thrombospondin-1 polypeptides exemplifies the impact of innovative research in the medical field. His contributions have the potential to advance treatment options for serious health conditions.